Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price

Royal Bank Of Canada dropped their price objective on shares of Eyepoint Pharmaceuticals from $5.00 to $1.00 and set a "sector perform" rating for the company in a research note…

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)